NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 218 filers reported holding NEVRO CORP in Q3 2020. The put-call ratio across all filers is 1.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $381,668 | +13.9% | 19,858 | +50.7% | 0.00% | 0.0% |
Q2 2023 | $335,075 | +41.2% | 13,181 | +100.8% | 0.00% | – |
Q1 2023 | $237,310 | +14.4% | 6,565 | +25.3% | 0.00% | – |
Q4 2022 | $207,524 | +1.2% | 5,240 | +19.1% | 0.00% | – |
Q3 2022 | $205,000 | -40.6% | 4,401 | -44.2% | 0.00% | -100.0% |
Q2 2022 | $345,000 | -40.3% | 7,892 | -1.2% | 0.00% | 0.0% |
Q1 2022 | $578,000 | -98.4% | 7,986 | -98.3% | 0.00% | -98.6% |
Q4 2021 | $37,032,000 | -26.5% | 456,822 | +5.5% | 0.07% | -34.9% |
Q3 2021 | $50,379,000 | +15.9% | 432,903 | +65.1% | 0.11% | +10.4% |
Q2 2021 | $43,480,000 | +54.5% | 262,256 | +30.4% | 0.10% | +35.2% |
Q1 2021 | $28,149,000 | -20.5% | 201,060 | -1.5% | 0.07% | -22.8% |
Q4 2020 | $35,404,000 | +46.4% | 204,216 | +17.5% | 0.09% | +31.4% |
Q3 2020 | $24,190,000 | +9.6% | 173,767 | -6.2% | 0.07% | +1.4% |
Q2 2020 | $22,081,000 | +44.9% | 185,349 | +21.3% | 0.07% | +23.2% |
Q1 2020 | $15,238,000 | -43.9% | 152,832 | -33.9% | 0.06% | -30.9% |
Q4 2019 | $27,163,000 | +6.2% | 231,101 | -22.3% | 0.08% | +24.6% |
Q3 2019 | $25,570,000 | +26.8% | 297,428 | -4.4% | 0.06% | -1.5% |
Q2 2019 | $20,172,000 | +50330.0% | 311,158 | +48901.3% | 0.07% | – |
Q1 2019 | $40,000 | -95.9% | 635 | -94.8% | 0.00% | -100.0% |
Q2 2018 | $975,000 | -8.3% | 12,218 | -0.4% | 0.00% | -25.0% |
Q1 2018 | $1,063,000 | +21160.0% | 12,268 | +17679.7% | 0.00% | – |
Q4 2017 | $5,000 | -96.9% | 69 | -96.2% | 0.00% | -100.0% |
Q3 2017 | $163,000 | +1.9% | 1,801 | -16.5% | 0.00% | 0.0% |
Q2 2017 | $160,000 | -80.9% | 2,156 | -75.8% | 0.00% | -75.0% |
Q1 2017 | $836,000 | +646.4% | 8,916 | +477.5% | 0.00% | +300.0% |
Q4 2016 | $112,000 | -16.4% | 1,544 | +20.0% | 0.00% | 0.0% |
Q3 2016 | $134,000 | +12.6% | 1,287 | -20.6% | 0.00% | 0.0% |
Q2 2016 | $119,000 | +83.1% | 1,620 | +40.0% | 0.00% | – |
Q1 2016 | $65,000 | -74.4% | 1,157 | -78.9% | 0.00% | -100.0% |
Q3 2015 | $254,000 | – | 5,482 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BRAIDWELL LP | 1,192,298 | $47,215,001 | 1.58% |
Altium Capital Management LP | 76,000 | $3,009,600 | 1.53% |
Rock Springs Capital Management LP | 1,077,900 | $42,684,840 | 1.03% |
Integral Health Asset Management, LLC | 109,000 | $4,316,400 | 0.91% |
ArrowMark Colorado Holdings LLC | 1,252,218 | $49,587,833 | 0.59% |
FOX RUN MANAGEMENT, L.L.C. | 26,963 | $1,067,735 | 0.43% |
PDT Partners, LLC | 55,715 | $2,206,314 | 0.36% |
FRED ALGER MANAGEMENT, LLC | 1,184,000 | $46,886,400 | 0.25% |
Dynamic Technology Lab Private Ltd | 62,819 | $2,488 | 0.25% |
K2 PRINCIPAL FUND, L.P. | 38,000 | $1,504,800 | 0.23% |